188 related articles for article (PubMed ID: 34830610)
1. Targeting the Gut Microbiome in Prader-Willi Syndrome.
Ramon-Krauel M; Amat-Bou M; Serrano M; Martinez-Monseny AF; Lerin C
J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830610
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.
Kong XJ; Liu K; Zhuang P; Tian R; Liu S; Clairmont C; Lin X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Yu Z; Shen C; Cui X; Cao H; Du T; Wan G; Cao X
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1508-1520. PubMed ID: 34115318
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Probiotic Supplementation on Anthropometric Growth and Gut Microbiota Composition in Patients With Prader-Willi Syndrome: A Randomized Double-Blinded Placebo-Controlled Trial.
Kong XJ; Wan G; Tian R; Liu S; Liu K; Clairmont C; Lin X; Zhang X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Liu J; Yu Z; Shen C; Cui X; Cao H; Du T; Cao X
Front Nutr; 2021; 8():587974. PubMed ID: 33681271
[No Abstract] [Full Text] [Related]
4. Altered Salivary Microbiota Following Bifidobacterium animalis Subsp. Lactis BL-11 Supplementation Are Associated with Anthropometric Growth and Social Behavior Severity in Individuals with Prader-Willi Syndrome.
Liu K; Kong XJ
Probiotics Antimicrob Proteins; 2022 Aug; 14(4):699-711. PubMed ID: 35474569
[TBL] [Abstract][Full Text] [Related]
5. Specific Dietary Components and Gut Microbiota Composition are Associated with Obesity in Children and Adolescents with Prader-Willi Syndrome.
Garcia-Ribera S; Amat-Bou M; Climent E; Llobet M; Chenoll E; Corripio R; Ibáñez L; Ramon-Krauel M; Lerin C
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32290434
[TBL] [Abstract][Full Text] [Related]
6. The effects of Bifidobacterium animalis ssp. lactis B94 on gastrointestinal wellness in adults with Prader-Willi syndrome: study protocol for a randomized controlled trial.
Alyousif Z; Miller JL; Sandoval MY; MacPherson CW; Nagulesapillai V; Dahl WJ
Trials; 2018 Apr; 19(1):256. PubMed ID: 29703235
[TBL] [Abstract][Full Text] [Related]
7. The Gut Microbiota Profile in Children with Prader-Willi Syndrome.
Peng Y; Tan Q; Afhami S; Deehan EC; Liang S; Gantz M; Triador L; Madsen KL; Walter J; Tun HM; Haqq AM
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32784572
[TBL] [Abstract][Full Text] [Related]
8. Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader-Willi Syndrome: A randomized, double-blind, crossover trial.
Alyousif Z; Miller JL; Auger J; Sandoval M; Piano A; Tompkins TA; Dahl WJ
Mol Genet Genomic Med; 2020 Dec; 8(12):e1535. PubMed ID: 33103385
[TBL] [Abstract][Full Text] [Related]
9. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome.
Bittel DC; Kibiryeva N; Butler MG
Pediatrics; 2006 Oct; 118(4):e1276-83. PubMed ID: 16982806
[TBL] [Abstract][Full Text] [Related]
10. [Psychological management of a patient with Prader Willi syndrome: case study of a young Moroccan girl].
Benchikhi L; Nafiaa H; Zaroual A; Ouanass A
Pan Afr Med J; 2019; 33():115. PubMed ID: 31489093
[TBL] [Abstract][Full Text] [Related]
11. Physiological adaptation after a 12-week physical activity program for patients with Prader-Willi syndrome: two case reports.
Amaro AS; Teixeira MC; de Mesquita ML; Rodrigues GM; Rubin DA; Carreiro LR
J Med Case Rep; 2016 Jun; 10(1):181. PubMed ID: 27339289
[TBL] [Abstract][Full Text] [Related]
12. Behavioral characteristics of Prader-Willi syndrome in Korea: comparison with children with mental retardation and normal controls.
Kim JW; Yoo HJ; Cho SC; Hong KE; Kim BN
J Child Neurol; 2005 Feb; 20(2):134-8. PubMed ID: 15794180
[TBL] [Abstract][Full Text] [Related]
13. Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy.
Zipf WB
Acta Paediatr Suppl; 1999 Dec; 88(433):115-7. PubMed ID: 10626560
[TBL] [Abstract][Full Text] [Related]
14. Decline of CSF orexin (hypocretin) levels in Prader-Willi syndrome.
Omokawa M; Ayabe T; Nagai T; Imanishi A; Omokawa A; Nishino S; Sagawa Y; Shimizu T; Kanbayashi T
Am J Med Genet A; 2016 May; 170A(5):1181-6. PubMed ID: 26738920
[TBL] [Abstract][Full Text] [Related]
15. The Prader-Willi syndrome: a study of 40 patients and a review of the literature.
Bray GA; Dahms WT; Swerdloff RS; Fiser RH; Atkinson RL; Carrel RE
Medicine (Baltimore); 1983 Mar; 62(2):59-80. PubMed ID: 6338343
[TBL] [Abstract][Full Text] [Related]
16. Somatropin therapy in adults with Prader-Willi syndrome.
Höybye C; Thorén M
Treat Endocrinol; 2004; 3(3):153-60. PubMed ID: 16026111
[TBL] [Abstract][Full Text] [Related]
17. Deletion analysis of the imprinting center region in patients with Angelman syndrome and Prader-Willi syndrome by real-time quantitative PCR.
Raca G; Buiting K; Das S
Genet Test; 2004; 8(4):387-94. PubMed ID: 15684868
[TBL] [Abstract][Full Text] [Related]
18. Prader-Willi syndrome: clinical and molecular cytogenetic investigations.
Hou JW; Wang TR
J Formos Med Assoc; 1996 Jun; 95(6):474-9. PubMed ID: 8772055
[TBL] [Abstract][Full Text] [Related]
19. [Self-induced cutaneous lesions in Prader-Willi syndrome].
Plantin P; Milochau P; Broussine L; Blondin G
Ann Dermatol Venereol; 1997; 124(5):390-2. PubMed ID: 9739896
[TBL] [Abstract][Full Text] [Related]
20. The Use of Probiotic Therapy in Metabolic and Neurological Diseases.
Lee SHF; Ahmad SR; Lim YC; Zulkipli IN
Front Nutr; 2022; 9():887019. PubMed ID: 35592636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
